p53 reactivation with induction of massive apoptosis-1 (PRIMA-1) inhibits amyloid aggregation of mutant p53 in cancer cellsLuciana P. Rangel, Jerson L. Silva, Danielly C. Ferraz da Costa et al.|Journal of Biological Chemistry|2019Cited by 86
Anticancer Potential of Resveratrol, β-Lapachone and Their AnaloguesDanielly C. Ferraz da Costa, Jerson L. Silva, Giulia D. S. Ferretti et al.|Molecules|2020Cited by 66
Loss of the p53 transactivation domain results in high amyloid aggregation of the Δ40p53 isoform in endometrial carcinoma cellsNataly Melo dos Santos, Etel Rodrigues Pereira Gimba, Jerson L. Silva et al.|Journal of Biological Chemistry|2019Cited by 50
Recent Synthetic Approaches towards Small Molecule Reactivators of p53Jerson L. Silva, Vı́tor F. Ferreira, Carolina G. S. Lima et al.|Biomolecules|2020Cited by 25
Anticancer Therapeutic Strategies Targeting p53 AggregationGiulia D. S. Ferretti, Jerson L. Silva, Julia Quarti et al.|International Journal of Molecular Sciences|2022Cited by 20